| Members |
acceptabilityId |
| rpT4b - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2023) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. |
Preferred (foundation metadata concept) |
| rpT4c |
Preferred (foundation metadata concept) |
| rpT4c - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2023) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. |
Preferred (foundation metadata concept) |
| rpT4d |
Preferred (foundation metadata concept) |
| rpT4d - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2023) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. |
Preferred (foundation metadata concept) |
| rpT4e |
Preferred (foundation metadata concept) |
| rpT4e - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2023) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. |
Preferred (foundation metadata concept) |
| rpTX |
Preferred (foundation metadata concept) |
| rpTX - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2023) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. |
Preferred (foundation metadata concept) |
| rpTa |
Preferred (foundation metadata concept) |
| rpTa - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2023) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. |
Preferred (foundation metadata concept) |
| rpTis |
Preferred (foundation metadata concept) |
| rpTis(DCIS) |
Preferred (foundation metadata concept) |
| rpTis(DCIS)- Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2023) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. |
Preferred (foundation metadata concept) |
| rpTis(LAMN) |
Preferred (foundation metadata concept) |
| rpTis(LAMN)- Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2023) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. |
Preferred (foundation metadata concept) |
| rpTis(Paget) |
Preferred (foundation metadata concept) |
| rpTis(Paget) - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2023) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. |
Preferred (foundation metadata concept) |
| rpTis- Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2023) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. |
Preferred (foundation metadata concept) |
| rpm |
Preferred (foundation metadata concept) |
| rt-PA - Tissue-type plasminogen activator |
Acceptable (foundation metadata concept) |
| ry phenotype |
Preferred (foundation metadata concept) |
| ry phenotype (finding) |
Preferred (foundation metadata concept) |
| s |
Preferred (foundation metadata concept) |
| s antigen |
Acceptable (foundation metadata concept) |
| s+ phenotype |
Preferred (foundation metadata concept) |
| s+ phenotype (finding) |
Preferred (foundation metadata concept) |
| s- phenotype |
Preferred (foundation metadata concept) |
| s- phenotype (finding) |
Preferred (foundation metadata concept) |
| sC - Specific compliance |
Acceptable (foundation metadata concept) |
| sFGR - selective fetal growth restriction |
Acceptable (foundation metadata concept) |
| sFGR - selective foetal growth restriction |
Acceptable (foundation metadata concept) |
| sIUGR - selective intrauterine growth restriction |
Acceptable (foundation metadata concept) |
| scoops per day |
Acceptable (foundation metadata concept) |
| scoops per meal |
Acceptable (foundation metadata concept) |
| scoops/24h |
Preferred (foundation metadata concept) |
| scoops/24h (qualifier value) |
Preferred (foundation metadata concept) |
| scoops/day |
Preferred (foundation metadata concept) |
| scoops/day (qualifier value) |
Preferred (foundation metadata concept) |
| scoops/feed |
Preferred (foundation metadata concept) |
| scoops/feed (qualifier value) |
Preferred (foundation metadata concept) |
| scoops/meal |
Preferred (foundation metadata concept) |
| scoops/meal (qualifier value) |
Preferred (foundation metadata concept) |
| scyllo-Inosamine kinase |
Preferred (foundation metadata concept) |
| scyllo-Inosamine kinase (substance) |
Preferred (foundation metadata concept) |
| sdCHC - stomatin-deficient cryohydrocytosis |
Acceptable (foundation metadata concept) |
| sec-Butyl acetate |
Preferred (foundation metadata concept) |
| sec-Butyl acetate (substance) |
Preferred (foundation metadata concept) |
| sec-Butyl acetate measurement |
Preferred (foundation metadata concept) |
| sec-Butyl acetate measurement (procedure) |
Preferred (foundation metadata concept) |
| sec-butanol |
Acceptable (foundation metadata concept) |
| seconds of arc |
Preferred (foundation metadata concept) |
| seconds of arc (qualifier value) |
Preferred (foundation metadata concept) |
| sex linked Lu(a-b-) phenotype |
Acceptable (foundation metadata concept) |
| siRNA - Small interfering RNA |
Acceptable (foundation metadata concept) |
| sn-Glycerol-3-phosphate 1-galactosyltransferase |
Preferred (foundation metadata concept) |
| sn-Glycerol-3-phosphate 1-galactosyltransferase (substance) |
Preferred (foundation metadata concept) |
| sn-Glycerol-3-phosphate 2-alpha-galactosyltransferase |
Preferred (foundation metadata concept) |
| sn-Glycerol-3-phosphate 2-alpha-galactosyltransferase (substance) |
Preferred (foundation metadata concept) |
| snRNP |
Acceptable (foundation metadata concept) |
| snRNP - Small nuclear ribonucleoprotein antibody |
Acceptable (foundation metadata concept) |
| sq. cm |
Preferred (foundation metadata concept) |
| sq. ft |
Preferred (foundation metadata concept) |
| sq. in |
Preferred (foundation metadata concept) |
| sq. m |
Preferred (foundation metadata concept) |
| sq. mm |
Preferred (foundation metadata concept) |
| sq. yd |
Preferred (foundation metadata concept) |
| square centimetre |
Acceptable (foundation metadata concept) |
| square centimetres |
Acceptable (foundation metadata concept) |
| square decimetre |
Acceptable (foundation metadata concept) |
| square metre |
Acceptable (foundation metadata concept) |
| square metres |
Acceptable (foundation metadata concept) |
| square millimetre |
Acceptable (foundation metadata concept) |
| square millimetres |
Acceptable (foundation metadata concept) |
| ssDNA - Single-stranded deoxyribonucleoprotein antibody |
Acceptable (foundation metadata concept) |
| ssDNA binding autoantibody level |
Preferred (foundation metadata concept) |
| ssDNA binding autoantibody level |
Preferred (foundation metadata concept) |
| ssDNA binding autoantibody level (procedure) |
Preferred (foundation metadata concept) |
| ssDNA binding autoantibody level (procedure) |
Preferred (foundation metadata concept) |
| ssRNA phage virus |
Acceptable (foundation metadata concept) |
| stat |
Acceptable (foundation metadata concept) |
| stones - unit |
Preferred (foundation metadata concept) |
| stones - unit (qualifier value) |
Preferred (foundation metadata concept) |
| sym-Norspermidine synthase |
Preferred (foundation metadata concept) |
| sym-Norspermidine synthase (substance) |
Preferred (foundation metadata concept) |
| t |
Preferred (foundation metadata concept) |
| t1 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
| t10 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
| t11 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
| t12 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
| t14 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
| t16 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
| t17 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
| t18 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
| t19 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
| t2 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
| t20 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
| t201 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
| t208 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
| t21 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
| t210 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |